Skip to main content
Year archive

BioSenic SA — 2017 filings

All 75 regulatory filings released by BioSenic SA (BIOS) in 2017, sourced directly from the official regulator.

75 Filings
2017 Period
2017 filings (75)
Filing Released Lang
PR_20171215_BT_Transaction Update_EN_Final.pdf
Capital/Financing Update
2017-12-14 English
PR_20171215_BT_Transaction Update_FR_Final.pdf
Regulatory Filings
2017-12-14 French
Bone Therapeutics Launches Equity Placement
Capital/Financing Update
2017-12-14 English
Bone Therapeutics annonce le lancement d’un placement privé
Share Issue/Capital Change
2017-12-14 French
20171030_BOTHE_AGE_PV.pdf
AGM Information
2017-11-13 French
PR_2017-11-09_BT_2017-Q3_EN_Final.pdf
Interim / Quarterly Report 9M 2017
2017-11-09 English
PR_2017-11-09_BT_2017-Q3_FR_Final.pdf
Interim / Quarterly Report 9M 2017
2017-11-09 French
20171005_BOTHE_AGE_PV_.pdf
AGM Information
2017-10-17 French
20171030_BOTHE_EGM_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2017-10-13 English
20171030_BOTHE_EGM_Procuration_FR.pdf
AGM Information
2017-10-13 French
20171030_BOTHE_EGM_Droits-actionnaires_EN.pdf
AGM Information
2017-10-13 English
PR_20171013_BT_Documents EGM 20171030_FR_Final.pdf
AGM Information
2017-10-13 French
PR_20171013_BT_Documents EGM 20171030_EN_Final.pdf
AGM Information
2017-10-13 English
20171030_BOTHE_EGM_Droits-actionnaires_FR.pdf
AGM Information
2017-10-13 French
20171030_BOTHE_EGM_Convocation_EN.pdf
AGM Information
2017-10-13 English
20171030_BOTHE_EGM_Convocation_FR.pdf
AGM Information
2017-10-13 French
Bone Therapeutics and Asahi Kasei sign exclusive license agreement for PREOB® in Japan
Regulatory Filings
2017-09-22 English
Bone Therapeutics et Asahi Kasei signent un accord de licence exclusive portant sur PREOB® au Japon
Regulatory Filings
2017-09-22 French
Bone Therapeutics announces all patients meet primary endpoint in ALLOB® Phase I/IIA delayed-union study interim analysis
Regulatory Filings
2017-09-20 English
Bone Therapeutics annonce que l’ensemble des patients ont satisfait au critère principal d’évaluation de l’analyse intérimaire de la Phase I/IIA dans les fractures avec retard de consolidation
Legal Proceedings Report
2017-09-20 French
Bone Therapeutics reports strong interim results from ALLOB® Phase IIA spinal fusion study
Earnings Release FY 2017
2017-09-14 English
Bone Therapeutics annonce des résultats intermédiaires robustes dans l’étude de phase IIA avec ALLOB® dans la fusion vertébrale
Earnings Release Q3 2017
2017-09-14 French
PR_2017-09-04_BT_Documents EGM 20171005_EN_Final.pdf
AGM Information
2017-09-04 English
PR_2017-09-04_BT_Documents EGM 20171005_FR_Final.pdf
AGM Information
2017-09-04 French
20171005_BOTHE_EGM_Droits-actionnaires_EN.pdf
AGM Information
2017-09-04 English
20171005_BOTHE_EGM_Procuration_FR.pdf
AGM Information
2017-09-04 French
20171005_BOTHE_EGM_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2017-09-04 English
20171005_BOTHE_EGM_Droits-actionnaires_FR.pdf
Proxy Solicitation & Information Statement
2017-09-04 French
20171005_BOTHE_EGM_Convocation_EN.pdf
AGM Information
2017-09-04 English
20171005_BOTHE_EGM_Convocation_FR.pdf
AGM Information
2017-09-04 French
PR_20170831_BT_H1 2017_EN_Final.pdf
Interim / Quarterly Report H1 2017
2017-08-31 English
PR_20170831_BT_H1 2017_FR_Final.pdf
Earnings Release H1 2017
2017-08-31 French
20170830_Bone Therapeutics_Interim Financial Report H1 2017_EN_Final.pdf
Interim / Quarterly Report H1 2017
2017-08-31 English
20170831_Bone Therapeutics_Rapport intermediaire S1 2017_FR_Final.pdf
Interim / Quarterly Report H1 2017
2017-08-31 French
20170526_BOTHE_AGO_PV.pdf
AGM Information
2017-06-08 French
Bone Therapeutics completes patient recruitment for pivotal interim analysis of Phase III Osteonecrosis trial with PREOB®
Legal Proceedings Report
2017-06-08 English
Bone Therapeutics finalise le recrutement des patients pour l’analyse intermédiaire de l’étude de Phase III avec PREOB® dans l’ostéonécrose
Regulatory Filings
2017-06-08 French
PR_2017-05-1_BT_2017-Q1_EN_Final.pdf
Interim / Quarterly Report Q1 2017
2017-05-11 English
PR_2017-05-1_BT_2017-Q1_FR_Final.pdf
Interim / Quarterly Report Q1 2017
2017-05-11 French
20170526_BOTHE_AGO_2017_Droits-actionnaires_FR.pdf
Proxy Solicitation & Information Statement
2017-04-26 French
PR_2017-04-26_BT_Documents AG 2017_EN_Final.pdf
AGM Information
2017-04-26 English
Comptes annuels 2016 BT.pdf
Annual Report FY 2016
2017-04-26 French
20170526_BOTHE_AGO_2017_Droits-actionnaires_EN.pdf
AGM Information
2017-04-26 English
AR_Bone Therapeutics_ Statutory 311216.pdf
Audit Report / Information FY 2016
2017-04-26 French
2017_04_25_CV candidates management-board.pdf
Governance Information
2017-04-26 English
20170526_BOTHE_AGO_2017_Procuration_FR.pdf
Proxy Solicitation & Information Statement
2017-04-26 French
20170526_BOTHE_AGO_2017_Procuration_EN.pdf
Proxy Solicitation & Information Statement
2017-04-26 English
PR_2017-04-26_BT_Documents AG 2017_FR_Final.pdf
AGM Information
2017-04-26 French
PR_2017-04-26_BT_Documents AG 2017_NL_Final.pdf
AGM Information
2017-04-26 Dutch
20170526_BOTHE_AGO_2017_Convocation_EN.pdf
AGM Information
2017-04-26 English
20170526_BOTHE_AGO_2017_Convocation_FR.pdf
AGM Information
2017-04-26 French
Bone Therapeutics_Annual Report_2016 _EN-LD_17259.pdf
Annual Report FY 2016
2017-04-25 English
Bone Therapeutics_Annual Report_2016 _FR-LD_17259.pdf
Annual Report FY 2016
2017-04-25 French
PR_2017-03-16_BT_FY2016_EN_Final_Long.pdf
Interim / Quarterly Report FY 2016
2017-03-16 English
PR_2017-03-16_BT_FY2016_FR_Final_Long.pdf
Earnings Release FY 2016
2017-03-16 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition du rapport financier annuel
Earnings Release FY 2016
2017-03-16 French
Document availability communications / Annual financial report
Earnings Release FY 2016
2017-03-16 English
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement
2017-03-10 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement
2017-03-10 French
Bone Therapeutics completes recruitment of 16 patients in ALLOB® Phase I/IIA delayed-union study
Regulatory Filings
2017-03-09 English
Bone Therapeutics annonce la fin du recrutement des 16 premiers patients de l’étude de Phase I/IIA avec ALLOB® dans les fractures avec retard de consolidation
Regulatory Filings
2017-03-09 French
Bone Therapeutics voltooit rekrutering van 16 patiënten in de ALLOB® Fase I/IIA studie voor vertraagd-helende breuken
Regulatory Filings
2017-03-09 Dutch
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2017-03-09 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Legal Proceedings Report
2017-03-09 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information
2017-03-06 French
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information
2017-03-06 English
Communicated under the obligation to provide permanent information / Other communications
Earnings Release FY 2016
2017-03-03 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement
2017-03-03 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Management Reports
2017-01-17 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings
2017-01-17 English
Bone Therapeutics Provides Business Update for Q4 2016
Earnings Release Q4 2016
2017-01-17 English
Bone Therapeutics publie son rapport d’activité du T4 2016
Earnings Release Q4 2016
2017-01-17 French
Bone Therapeutics Business Update Vierde Kwartaal 2016
Earnings Release Q4 2016
2017-01-17 Dutch
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Capital/Financing Update
2017-01-06 French
Communicated under the obligation to provide permanent information / Other communications
Capital/Financing Update
2017-01-06 English